Blindness due to cataract: Epidemiology and prevention

Annual Review of Public Health

Volumn 17, Issue , 1996, Pages 159-177

  Javitt, Jonathan C ^a   Wang, Fang ^a   West, Sheila K ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

blindness; cataract; cost; epidemiology; prevention; risk factor

Indexed keywords

BLINDNESS; CATARACT; CATARACT EXTRACTION; CONFERENCE PAPER; HEALTH SERVICE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; VISUAL ACUITY;

EID: 0030003754     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pu.17.050196.001111     Document Type: Conference Paper

References (115)

1. Adamsons I, Munoz B, Enger C, Taylor HR. 1991. Prevalence of lens opacities in surgical and general population. Arch. Ophthalmol. 109:993-97
2. Bochow TW, West SK, Azar A, Muñoz B, Sommer A, Taylor HR. 1989. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch. Ophthalmol. 107:369-72
3. Brenner MH, Curbow B, Javitt JC, Legro MW, Sommer A. 1993. Vision change and quality of life in the elderly. Response to cataract surgery and treatment of other chronic ocular conditions. Arch. Ophthalmol. 111:680-85
4. Brilliant GE, Brilliant LB. 1985. Using social epidemiology to understand who stays blind and who gets operated for cataract in a rural setting. Soc. Sci. Med. 21:553-58
5. Brilliant GE, Lepkowski JM, Zurita B, Thulasiraj RD. 1991. Social determinants of cataract surgery utilization in South India. Arch. Ophthalmol. 109: 584-89
6. Brilliant LB, Grasset NC, Pokhrel RP, Kolstad A, Lepkowski JM, et al. 1983. Associations among cataract prevalence, sunlight hours, and altitude in the Himalayas. Am. J. Epidemiol. 118:250-64
7. Brilliant LB, Pokhrel RP, Grasset NC, Lepkowski JM, Kolstad A, et al. 1985. Epidemiology of blindness in Nepal. Bull. WHO. 63:375-86
8. Bunce GE, Kinoshita J, Horwitz J. 1990. Nutritional factors in cataract. Annu. Rev. Nutr. 10:233-54
9. Canner JK, Javitt JC, McBean MA. 1992. National outcomes of cataract extraction III. Corneal edema and transplant following inpatient surgery. Arch. Ophthalmol. 110:1137-42
10. Cataract Panel. 1983. Report. Vision research: a national plan 1983-87. Part 3. NIH publ 83-2473. Washington, DC: US DHHS
11. Cent. Dis. Control. 1983. Cataract - a major blinding condition. Morbid. Mortal. Wkly. Rep. 32:119-20
12. Chatterjee A, Milton RC, Thyle S. 1982. Prevalence and aetiology of cataract in Punjab. Br. J. Ophthalmol. 66:35-42
13. Chew EY, Williams GA, Burton TC, Remaley MA, Ferris FL. 1992. Aspirin effects on the development of cataracts in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study rep. 16. Arch. Ophthalmol. 110:339-42
14. Christen WG, Manson JE, Seddon JM, Glynn RJ, Buring JE, et al. 1992. A prospective study of cigarette smoking and risk of cataract in men. JAMA 268: 989-93
15. Christy NE, Lall P. 1973. Postoperative endophthalmitis following cataract surgery. Arch. Ophthalmol. 90:361-66
16. Chylack LT Jr, Leske MA, Sperduto R, Khu P, McCarthy D, Lens Opacities Case-control Study Group. 1988. Lens opacities classification system. Arch. Ophthalmol. 106:330-34
17. Clayton RM, Cuthbert J, Seth J, Phillips Cl, Bartholomew RS, et al. 1984. Epidemiological and other studies in the assessment of factors contributing to cataractogenesis. Ciba Found. Symp. 106: 25-47
18. Collman GW, Shore DL, Shy CM, Checkway H, Luria AS. 1988. Sunlight and other risk factors for cataracts: an epidemiologic study. Am. J. Public Health 78:1459-62
19. Cotlier E. 1988. Senile cataracts: evidence for acceleration by diabetes and deceleration by salicylate. Can. J. Ophthalmol. 16:113-18
20. Cruickshanks KJ, Klein BEK, Klein R. 1992. Ultraviolet light exposure and lens opacities: the Beaver Dam Eye Study. Am. J. Public. Health. 82:1658-62
21. Deleted in proof
22. Dolin PJ. 1994. Ultraviolet radiation and cataract: a review of the epidemiological evidence. Br. J. Ophthalmol. 78:478-82
23. Drummond MF. 1992. Economic aspects of cataract blindness. In World Blindness and Its Prevention, ed. C Kupfer, T Gillen, pp. 157-70. Int. Agency Prevent. Blindness. Vol. 4.
24. Egbert PR, Buchanan M. 1991. Results of extracapsular cataract surgery and intraocular lens implantation in Ghana. Arch. Ophthalmol. 109:1761-63
25. Escarce JJ. 1993. Would eliminating differences in physician practice style reduce geographic variations in cataract survey rates? Med. Care 31:1106-18
26. Flaye DE, Sullivan KN, Cullinan TR, Silver JH, Whitelock RA. 1989. Cataracts and cigarette smoking. The City Eye Study. Eye 3:379-84
27. Foster A. 1991. Who will operate on African's 3 million curable blind people. Lancet 337:1267-69
28. Framingham Offspring Eye Study Group. 1994. Familial aggregation of lens opacities: the Framingham eye study and the Framingham Offspring eye study. Am. J. Epidemiol. 140:555-64
29. Deleted in proof
30. Hankinson SE, Seddon JM, Colditz GA, Stampfer MJ, Rosner B, et al. 1993. A prospective study of aspirin use and cataract extraction in women. Arch. Ophthalmol. 111:503-8
31. Hankinson SE, Stampfer MJ, Seddon JM, Colditz GA, Rosner B, et al. 1992. Nutrient intake and cataract extraction in women: a prospective study. Br. Med. J. 305:335-39
32. Hankinson SE, Willett WC, Colditz GA, Seddon JM, Rosner B, et al. 1992. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA. 268:994-98
33. Harding JJ, Egerton M, Harding RS. 1989. Protection against cataract by aspirin, paracetamol and ibuprofen. Acta Ophthalmol. 67:518-24
34. Harding JJ, van Heyningen R. 1988. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br. J. Ophthalmol. 72:809-14
35. Harding JJ, van Heyningen R. 1989. Beer, cigarettes and military work as risk factors for cataract. Dev. Ophthalmol. 17:13-16
36. Heiba IM, Elston RC, Klein BEK, Klein R. 1993. Genetic etiology of nuclear cataract: evidence for major gene. Am. J. Med. Genet. 47:1208-14
37. Heiba IM, Elston RC, Klein BEK, Klein R. 1995. Evidence for a major gene for cortical cataract. Invest. Ophthalmol. Vis. Sci. 36:227-35
38. Hiller R, Giacometti L, Yuen K. 1977. Sunlight and cataract: an epidemiologic investigation. Am. J. Epidemiol. 105: 450-59
39. Hiller R, Sperduto RD, Ederer F. 1983. Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey. Am. J. Epidemiol. 118:239-49
40. Hiller R, Sperduto RD, Ederer F. 1986. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am. J. Epidemiol. 124:916-25
41. HKI (Helen Keller International). 1985. Kongwa Primary Health Care Report 1984-85. New York
42. Hollows F, Moran D. 1981. Cataract - the ultraviolet risk factor. Lancet 2: 1249-50
43. Hu Z, Zhao JL, Dong FT, et al. 1989. Survey of cataract in Shunyi County, Beijing. Chin. J. Ophthalmol. 25:360-64
44. Italian-American Cataract Study Group. 1991. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am. J. Epidemiol. 133:541-53
45. Italian-American Cataract Study Group. 1994. Incidence and progression of cortical, nuclear, and posterior subcapsular cataracts. Am. J. Ophthalmol. 118:623-31
46. Jacques PF, Chylack LT, McGandy RB, Hartz SC. 1988. Antioxidant status in persons with and without senile cataract. Arch. Ophthalmol. 106:337-40
47. Jacques PF, Hartz SC, Chylack LT Jr, McGandy RB, Sadowski JA. 1988. Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. Am. J. Clin. Nutr. 48: 152-58
48. Javilt JC. 1993. Cataract. In Disease Control Priorities in Developing Countries, ed. DT Jamison, WH Mosley, AR Measham, JL Bobadilla, pp. 635-45. Oxford: Oxford Med. Publ.
49. Javitt JC. 1993. The cost-effectiveness of restoring sight. Arch. Ophthalmol. 111:1615
50. 49a. Javitt JC. 1993. Cost-effectiveness of cataract surgery. Oral presentation. Am. Acad. Ophthalmol.
51. Javitt JC, Brenner MH, Curbow B, Legro MW, Street DA. 1993. Outcomes of cataract surgery. Improvement in visual acuity and subjective visual function after surgery in the first, second, and both eyes. Arch. Ophthalmol. 111:686-91
52. Javitt JC, Kendix M, Tielsch JM, Steinwachs DM, Schein OD, Kolb MM, et al. 1995. Geographic variation in utilization of cataract surgery. Med. Care 33:90-105
53. Javitt JC, Street DA, Tielsh JM, Wang Q, Kolb MM, et al. 1994. National outcomes of cataract extraction. Retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology 101:100-5
54. Javitt JC, Taylor HR. 1995. Cataract and latitude. Doc. Ophthalmol. 88:307-25
55. Javitt JC, Tielsch JM, Canner JK, Kolb MM, Sommer A, Steinberg EP. 1992. National outcome of cataract extraction I. Increased risk of retinal complications associated with Nd:YAG laser capsulotomy. Ophthalmology 99:1487-98
56. Javitt JC, Vitale S, Canner JK, Krakauer H, McBean AM, Sommer A. 1991. National outcomes of cataract extraction. Retinal detachment after inpatient surgery. Ophthalmology 98:895-902
57. Javitt JC, Vitale S, Canner JK, Street DA, Krakauer H, et al. 1991. National outcomes of cataract extraction. Endophthalmitis following inpatient surgery. Arch. Ophthalmol. 109:1085-89
58. Kahn HA, Leibowitz HM, Ganley JP, et al. 1977. The Framingham Eye Study. I. Outline and major prevalence findings. Am. J. Epidemiol. 106:17-32
59. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, et al. 1977. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am. J. Epidemiol. 106:33-41
60. Karasik A, Modan M, Halkin H, Trister G, Fuchs Z, et al. 1984. Senile cataract and glucose intolerance: the Israel Study of Glucose Intolerance Obesity and Hypertension (The Israel GOH Study). Diabetes Care 7:52-56
61. Klein BEK, Klein R, Linton KLP. 1992. Prevalence of age-related lens opacities in a population. Ophthalmology 99:546-52
62. Klein BEK, Klein R, Linton KLP, Franke T. 1993. Diagnostic X-ray exposure and lens opacities: the Beaver Dam Eye Study. Am. J. Public Health 83:588-90
63. Klein BEK, Klein R, Linton KLP, Franke T. 1993. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am. J. Prev. Med. 9:27-30
64. Klein BEK, Klein R, Linton KLP, Magli YL, Neider NW. 1990. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 97:1428-33
65. Klein BEK, Klein R, Moss SE. 1985. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 92:1191-96
66. Klein BEK, Klein R, Moss SE. 1987. Is aspirin use associated with lower rates of cataracts in diabetic individuals? Diabetes Care 10:495-99
67. Klein BEK, Klein R, Moss SE. 1995. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of diabetic retinopathy. Am. J Ophthalmol. 119: 295-300
68. Knekt P, Heliövaara M, Rissanen A, Aromaa A, Aaran RK. 1992. Serum antioxidant vitamins and risk of cataract. Br. Med J. 305:1392-94
69. Leibowitz HM, et al. 1980. The Framingham Eye Study Monograph. Surv. Ophthalmol. 24(Suppl.):335-610
70. Leske MC, Chylack LT Jr, Wu S-Y, the Lens Opacities Case-Control Study Group. 1991. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch. Ophthalmol. 109:244-51
71. Leske MC, Sperduto RD. 1983. The epidemiology of senile cataracts: a review. Am. J. Epidemiol. 118:152-65
72. Mao WS, Hu TS. 1982. An epidemiologic survey of senile cataract in China. Chin. Med. J. 95:813-18
73. 71a. Mares-Perlman JA, Brady WE Klein BEK, Klein R, Haus GJ, et al. 1995. Diet and nuclear lens opacities. Am. J. Epidemiol. 141:322-34
74. 71b. Mares-Perlman JA, Brady WE, Klein BEK, Klein R, Palta M, et al. 1995. Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. Invest. Ophthalmol. Vis. Sci. 36: 276-88
75. 71c. Mares-Perlman JA, Klein BE, Klein R, Ritter LL. 1994. Relation between lens opacitites and vitamin and mineral supplements use. Ophthalmology 101:315-25
76. Minassian DC, Mehra V. 1990. 3.8 million blinded by cataract each year: projections from the first epidemiological study of incidence of cataract blindness in India. Br. J. Ophthalmol. 74:341-43
77. Mohan M, Sperduto RD, Angra SK, Milton RC, Mathur RL, et al. 1989. India-US case-control study of age-related cataracts. Arch. Ophthalmol. 107: 670-76
78. Muñoz B, Tajchman U, Bochow T, West S. 1993. Alcohol use and risk of posterior subcapsular opacities. Arch. Ophthalmol. 111:110-12
79. Muñoz B, West S, Vitale S, Schein OD, Maguire M, Taylor HR. 1993. Alcohol use and cataract in a cohort of Chesapeake Bay watermen. (Abstract). Invest. Ophthalmol. Vis. Sci. 34(Suppl.): 1066
80. Paganini-Hill A, Chao A, Ross RK, Henderson BE. 1989. Aspirin use and chronic diseases: a cohort study of the elderly. Br. Med. J. 299:1247-50
81. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, et al. 1988. Randomised trial of prophylactic daily aspirin in British male doctors. Br. Med. J. 296:313-16
82. Podgor MJ, Leske MC, Ederer F. 1983. Incidence estimates for lens changes, macular changes, open angle glaucoma and diabetic retinopathy. Am. J. Epidemiol 118:206-12
83. Ritter LL, Klein BEK, Klein R, Mares-Perlman JA. 1993. Alcohol use and lens opacities in the Beaver Dam Eye Study. Arch. Ophthalmol. 111:113-17
84. Robertson JMcD, Donner AP, Trevithick JR. 1991. A possible role for vitamins C and E in cataract prevention. Am. J. Clin. Nutr. 53:346S-51S
85. Ruit S, Robin AL, Pokrel RP, Sharma A, Defaller J. 1991. Extracapsular cataract extraction in Nepal: 2-year outcome. Arch. Ophthalmol. 109:1761-63
86. Schein OD, Steinberg EP, Javitt JC, Cassard SD, Tielsch JM, et al. 1994. Variation in cataract surgery practice and clinical outcomes. Ophthalmology 101:1142-52
87. Seddon JM, Christen WG, Manson JE, Burning JE, Sperduto RD, Hennekens CH. 1991. Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch. Ophthalmol. 109:252-55
88. Seigel D, Sperduto RD, Ferris FL III. 1982. Aspirin and cataracts. Ophthalmology 89:47A-9A
89. Sharkness CM, Hamburger S, Kaczmarek RG, Hamilton PM, Bright RA, Moore RM. 1992. Racial differences in the prevalence of intraocular lens implants in the United States. Am. J. Ophthalmol. 114:667-74
90. Deleted in proof
91. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD. 1991. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N. Engl. J. Med. 325:1412-17
92. Sparrow JM, Bron AJ, Brown NAP, Ayliffe W, Hill AR. 1986. The Oxford Clinical Cataract Classification and Grading System. Int. Ophthalmol. 9: 207-25
93. Sperduto RD. 1994. Age-related cataracts: scope of problem and prospects for prevention. Prev. Med. 23:735-39
94. Sperduto RD, Hu T-S, Milton RC, Zhao JL, Everett DF, et al. 1993. The Linxian Cataract Studies. Two nutrition intervention trials. Arch. Ophthalmol. 111: 1246-53
95. Steinberg EP, Bergner M, Sommer A, et al. 1990. Variations in cataract management: patient and economic outcomes. Health Serv. Res. 25:727-31
96. Steinberg EP, Javitt JC, Sharkey PD, Zuckerman A, Legro MW, et al. 1993. The content and cost of cataract surgery. Arch. Ophthalmol. 111:1041-48
97. Taylor HR, West SK, Rosenthal FS, Muñoz B, Newland HS, et al. 1988. Effect of ultraviolet radiation on cataract formation. N. Engl. J. Med. 319:1429-33
98. Taylor HR, West SK. 1989. The clinical grading of lens opacities. Aust. NZ J. Ophthalmol. 17:81-86
99. Thylefors B. 1990. The World Health Organization's programme for the prevention of blindness. Int. Ophthalmol. 14:211-19
100. 95a. Thylefors B, Négrel AP, Pararajasegaram R, Dadzie KY. 1995. Global data on blindness. Bull. WHO 73:115-21
101. Tielsch JM. 1994. Vision Problems in the U.S. Prevent Blindness America, Schaumburg, IL.
102. Tielsch JM, Javilt JC, Coleman A, Katz J, Sommer A. 1995. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N. Engl. J. Med 332:1205-9
103. UK-TIA Study Group. 1992. Does aspirin affect the rate of cataract formation? Cross-sectional results during a randomised double-blind placebo controlled trial to prevent serious vascular events. Br. J. Ophthalmol. 76: 259-61
104. 98a. van Heyingen R. 1972. The human lens. I. A comparison of cataracts extracted in Oxford (England) and Shikapur (W. Pakistan). Exp. Eye Res. 13:136-47
105. Venkataswamy G. 1987. Cataract in the Indian subcontinent. Ophthal. Surg. 18: 464-66
106. Venkataswamy G, Brilliant G. 1981. Social and economic barriers to cataract surgery in rural south India. Vis. Impair. Blind. Dec.:405-68
107. Vitale S, West S, Hallfrisch J, et al. 1993. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology 4:195-203
108. West S. 1992. Does smoke get in your eyes? JAMA 268:1025-26
109. West S, Muñoz B, Emmett EA, Taylor HR. 1989. Cigarette smoking and risk of nuclear cataracts. Arch. Ophthalmol. 107:1166-69
110. West SK, Muoz BE, Newland HS, Emmett EA, Taylor HR. 1987. Lack of evidence for aspirin use and prevention of cataracts. Arch. Ophthalmol. 105: 1229-31
111. West SK, Quigley HQ. 1991. Cataract blindness: what to do? Arch. Ophthalmol. 109:1765-66
112. West SK, Rosenthal F, Newland HS, Taylor HR. 1988. Use of photographic techniques to grade nuclear cataracts. Invest. Ophthalmol. Vis. Sci. 29:73-77
113. West SK, Valmadrid CT. 1995. Epidemiology of risk factors for age-related cataract. Surv. Ophthalmol. 39: 323-34
114. WHO (World Health Organization). 1987. Programme for the Prevention of Blindness. A vailable Data on Blindness. 87.14:1-23.34, Geneva
115. Zigman S, Datiles M, Torczynski E. 1979. Sunlight and human cataracts. Invest. Ophthalmol. Vis. Sci. 18:462-67